Vistagen Therapeutics files for $350M mixed shelf

• Vistagen Therapeutics (NASDAQ:VTGN) Tuesday filed a prospectus related to a mixed shelf offering of up to $350M.
• This prospectus is not an offer to sell these securities.
• SEC Filing

More on VistaGen Therapeutics

• VistaGen: Positive Data Leads To Catalysts In 2024 And Beyond
• Vistagen shares move up after Jefferies upgrade
• Seeking Alpha’s Quant Rating on VistaGen Therapeutics
• Historical earnings data for VistaGen Therapeutics
• Financial information for VistaGen Therapeutics